TELA Bio, Inc.
TELA
$0.57
-$0.05-8.26%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -5.09% | 13.30% | 11.91% | -22.33% | 11.22% |
| Total Depreciation and Amortization | -9.27% | -8.15% | 1.12% | 0.38% | 1.14% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 35.18% | 50.04% | -25.39% | -24.91% | 32.31% |
| Change in Net Operating Assets | 103.01% | 53.68% | 163.39% | 45.07% | -43.01% |
| Cash from Operations | 14.85% | 27.65% | 18.71% | -29.13% | 16.16% |
| Capital Expenditure | 56.87% | -85.09% | -256.25% | 87.88% | -116.39% |
| Sale of Property, Plant, and Equipment | -45.89% | 64.47% | 87.06% | 129.73% | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -38.46% | 52.94% | 47.83% | 172.63% | -55.74% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 26,173.33% | -- | -100.00% | -99.86% | 36,582.91% |
| Repurchase of Common Stock | 80.95% | -600.00% | 98.31% | -1,509.09% | 42.11% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 107,587.50% | 900.00% | 97.41% | -100.27% | 43,683.67% |
| Foreign Exchange rate Adjustments | -133.65% | 168.42% | -13.43% | -173.63% | 196.81% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 500.30% | 32.80% | 20.14% | -127.81% | 484.65% |